Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3509PDF: 2389HTML: 1446 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3647PDF: 1423HTML: 176 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4066PDF: 1572HTML: 920 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2895PDF: 873HTML: 1572 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
747PDF: 77HTML: 132 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4014PDF: 1137HTML: 1925Fig.1: 213Fig. 2: 105Table 1: 199Table2: 215Table 3: 196 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2501PDF: 864HTML: 2116 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3158PDF: 1418HTML: 5839Fig1-Ag-Pil: 219Ag-Pil Fig.2: 221 -
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4021PDF: 3322HTML: 192 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1274HTML: 294PDF: 924Suppl. Files: 440 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4385PDF: 1618HTML: 3586Tables and Images: 213 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2862PDF: 1351HTML: 3561Untitled: 188Untitled: 198Untitled: 173 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2140PDF: 1457HTML: 258 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2366PDF: 847HTML: 2448 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3182PDF: 997HTML: 2013 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2068PDF: 1659HTML: 361 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3274PDF: 1946HTML: 7466 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3285PDF: 1230HTML: 2189 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3162PDF: 767HTML: 2935Figure 1a and 1b: 144Figure 2: 154Figure 3: 173Figure 4: 155Figure 5: 159Tables 1-5: 150 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1721PDF: 987HTML: 1776Tables: 177 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3711PDF: 1457HTML: 475Figures . Eliassian: 215 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4283PDF: 1478HTML: 1539Untitled: 222 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3493PDF: 1540HTML: 69 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1670PDF: 751HTML: 484 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2462PDF: 832HTML: 8803Efremov 1: 219Efremov 2: 181 -
Simultaneous dual pathology in lymph node
1634PDF: 685HTML: 7683Simultaneous dual pathology in lymph node: 172Simultaneous dual pathology in lymph node: 169Simultaneous dual pathology in lymph node: 148Simultaneous dual pathology in lymph node: 186Simultaneous dual pathology in lymph node: 172 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2571PDF: 1600HTML: 2346Table1: 187 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1532PDF: 874HTML: 972figures: 175table 1: 178table2: 177table3: 178 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1230PDF: 469HTML: 18555Figure 1: 163Figure 2: 146Figure 3: 164Figure 4: 199Figure 5: 172 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2197PDF: 952HTML: 1883 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1105PDF: 503HTML: 176 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1262PDF: 605HTML: 3068 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2233PDF: 1804HTML: 133 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1236PDF: 477HTML: 131 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1748PDF: 680HTML: 2399Untitled: 147Figure 1 a: 152Figure 1 b: 162Fig 1 c: 144Figure 1 d: 190







